Antimicrobial Use in Patients with Dementia: Current Concerns and Future Recommendations Carole ParsonsJenny T. van der Steen Current Opinion 28 March 2017 Pages: 433 - 438
Pregnancy Outcomes Following In Utero Exposure to Lamotrigine: A Systematic Review and Meta-Analysis Gali ParienteTom LeibsonIrena Nulman Systematic Review 22 April 2017 Pages: 439 - 450
Erratum to: Pregnancy Outcomes Following In Utero Exposure to Lamotrigine: A Systematic Review and Meta-Analysis Gali ParienteTom LeibsonIrena Nulman Erratum 17 May 2017 Pages: 451 - 451
Cell Therapy for Multiple Sclerosis Pamela SarkarClaire M. RiceNeil J. Scolding Review Article 10 April 2017 Pages: 453 - 469
Achieving Smoking Cessation in Individuals with Schizophrenia: Special Considerations Corinne CatherGladys N. PachasA. Eden Evins Review Article 26 May 2017 Pages: 471 - 481
Impact of Muscarinic M3 Receptor Antagonism on the Risk of Type 2 Diabetes in Antidepressant-Treated Patients: A Case-Controlled Study Yen-Hao TranCatharina C. M. Schuiling-VeningaBob Wilffert Original Research Article Open access 19 May 2017 Pages: 483 - 493
Elucidating the Aβ42 Anti-Aggregation Mechanism of Action of Tramiprosate in Alzheimer’s Disease: Integrating Molecular Analytical Methods, Pharmacokinetic and Clinical Data Petr KocisMartin TolarJohn A. Hey Original Research Article Open access 24 April 2017 Pages: 495 - 509
Erratum to: Adherence and Persistence Across Antidepressant Therapeutic Classes: A Retrospective Claims Analysis Among Insured US Patients with Major Depressive Disorder (MDD) Katelyn R. KeylounRyan N. HansenEmily Beth Devine Erratum 27 April 2017 Pages: 511 - 511
Cariprazine: A Review in Schizophrenia Karly P. Garnock-Jones Adis Drug Evaluation 30 May 2017 Pages: 513 - 525